isocarboxazid has been researched along with Cancer of Liver in 1 studies
Isocarboxazid: An MAO inhibitor that is effective in the treatment of major depression, dysthymic disorder, and atypical depression. It also is useful in the treatment of panic disorder and the phobic disorders. (From AMA, Drug Evaluations Annual, 1994, p311)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Delacretaz, J | 1 |
| Emch, M | 1 |
| Schellhorn, JP | 1 |
1 other study available for isocarboxazid and Cancer of Liver
| Article | Year |
|---|---|
[Distribution of DL-3 (3,4-dihydroxyphenyl)-alanine-2 C14 in the organism of mice with Cloudmann's S91 melanoma].
Topics: Adrenal Gland Neoplasms; Animals; Carbon Isotopes; Computers; Dihydroxyphenylalanine; Isocarboxazid; | 1970 |